Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia - PubMed (original) (raw)
Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia
P Hedera et al. Neuroradiology. 2005 Oct.
Free article
Abstract
Hereditary spastic paraplegia (HSP) is a genetically heterogeneous group of neurodegenerative disorders characterized by progressive lower extremity weakness and spasticity. HSP pathology involves axonal degeneration that is most pronounced in the terminal segments of the longest descending (pyramidal) and ascending (dorsal columns) tracts. In this study, we compared spinal cord magnetic resonance imaging (MRI) in 13 HSP patients with four different types of autosomal dominant hereditary spastic paraplegia (SPG3A, SPG4, SPG6, and SPG8) with age-matched control subjects. The cross-section area of HSP subjects at cervical level C2 was 59.42 +/- 12.57 mm2 and at thoracic level T9 was 28.58 +/- 5.25 mm2. Both of these values were less than in the healthy controls (p < 0.001). The degree of cord atrophy was more prominent in patients with SPG6 and SPG8 who had signs of severe cord atrophy (47.60 +/- 6.58 mm2 at C2, 21.40 +/- 2.4 mm2 at T9) than in subjects with SPG3 and SPG4 (66.0 +/- 8.94 mm2 at C2, p < 0.02; 31.75 +/- 2.76 mm2 at T9, p < 0.001). These observations indicate that spinal cord atrophy is a common finding in the four genetic types of HSP. Spinal cord atrophy was more severe in SPG6 and SPG8 HSP subjects than in other types of HSP we studied. This may suggest a different disease mechanism with more prominent axonal degeneration in these two types of HSP when compared with HSP due to spastin and atlastin mutations.
Similar articles
- Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.
Fink JK. Fink JK. Acta Neuropathol. 2013 Sep;126(3):307-28. doi: 10.1007/s00401-013-1115-8. Epub 2013 Jul 30. Acta Neuropathol. 2013. PMID: 23897027 Free PMC article. Review. - Magnetic resonance investigation of the upper spinal cord in pure and complicated hereditary spastic paraparesis.
Sperfeld AD, Baumgartner A, Kassubek J. Sperfeld AD, et al. Eur Neurol. 2005;54(4):181-5. doi: 10.1159/000090294. Epub 2005 Dec 13. Eur Neurol. 2005. PMID: 16352904 - Multimodal MRI-based study in patients with SPG4 mutations.
Rezende TJ, de Albuquerque M, Lamas GM, Martinez AR, Campos BM, Casseb RF, Silva CB, Branco LM, D'Abreu A, Lopes-Cendes I, Cendes F, França MC Jr. Rezende TJ, et al. PLoS One. 2015 Feb 6;10(2):e0117666. doi: 10.1371/journal.pone.0117666. eCollection 2015. PLoS One. 2015. PMID: 25658484 Free PMC article. - Phenotypic analysis of autosomal dominant hereditary spastic paraplegia linked to chromosome 8q.
Hedera P, DiMauro S, Bonilla E, Wald J, Eldevik OP, Fink JK. Hedera P, et al. Neurology. 1999 Jul 13;53(1):44-50. doi: 10.1212/wnl.53.1.44. Neurology. 1999. PMID: 10408535 - Hereditary spastic paraplegia.
Fink JK. Fink JK. Neurol Clin. 2002 Aug;20(3):711-26. doi: 10.1016/s0733-8619(02)00007-5. Neurol Clin. 2002. PMID: 12432827 Review.
Cited by
- Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.
Fink JK. Fink JK. Acta Neuropathol. 2013 Sep;126(3):307-28. doi: 10.1007/s00401-013-1115-8. Epub 2013 Jul 30. Acta Neuropathol. 2013. PMID: 23897027 Free PMC article. Review. - The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1.
Botzolakis EJ, Zhao J, Gurba KN, Macdonald RL, Hedera P. Botzolakis EJ, et al. Mol Cell Neurosci. 2011 Jan;46(1):122-35. doi: 10.1016/j.mcn.2010.08.012. Epub 2010 Sep 21. Mol Cell Neurosci. 2011. PMID: 20816793 Free PMC article. - Hereditary Spastic Paraplegia: From Genes, Cells and Networks to Novel Pathways for Drug Discovery.
Mackay-Sim A. Mackay-Sim A. Brain Sci. 2021 Mar 22;11(3):403. doi: 10.3390/brainsci11030403. Brain Sci. 2021. PMID: 33810178 Free PMC article. Review. - Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations.
Chen J, Zhao Z, Shen H, Bing Q, Li N, Guo X, Hu J. Chen J, et al. BMC Neurol. 2022 May 16;22(1):180. doi: 10.1186/s12883-022-02708-z. BMC Neurol. 2022. PMID: 35578252 Free PMC article. - ARL6IP1 gene delivery reduces neuroinflammation and neurodegenerative pathology in hereditary spastic paraplegia model.
Lim JH, Kang HM, Kim DH, Jeong B, Lee DY, Lee JR, Baek JY, Cho HS, Son MY, Kim DS, Kim NS, Jung CR. Lim JH, et al. J Exp Med. 2024 Jan 1;221(1):e20230367. doi: 10.1084/jem.20230367. Epub 2023 Nov 7. J Exp Med. 2024. PMID: 37934410 Free PMC article.
References
- Neurology. 2000 Jul 12;55(1):89-94 - PubMed
- Nat Genet. 1999 Nov;23(3):296-303 - PubMed
- Arch Neurol. 2003 Aug;60(8):1045-9 - PubMed
- Am J Hum Genet. 1999 Feb;64(2):563-9 - PubMed
- Ann Neurol. 2000 Jul;48(1):108-12 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous